Financials
Income statement
| Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 19.8B | 20.2B | 16.9B | 15.6B |
| Cost of revenue | 16.6B | 16.6B | 14.4B | 13.4B |
| Gross profit | 3.2B | 3.6B | 2.5B | 2.2B |
| Operating expense | ||||
| Research & development | 693.0M | 679.4M | 712.8M | 653.7M |
| Selling general and admin | 768.6M | 716.4M | 648.7M | 621.9M |
| Other operating expenses | — | — | — | — |
| Operating income | 1.8B | 2.2B | 1.2B | 923.3M |
| Non operating interest income | ||||
| Income | 114.9M | 112.0M | 127.1M | 117.2M |
| Expense | 90.3M | 125.1M | 134.6M | 117.7M |
| Other income expense | — | — | — | — |
| Pretax income | 2.1B | 2.3B | 1.4B | 1.3B |
| Tax provision | 469.6M | 497.9M | 223.1M | 280.2M |
| Net income | 1.7B | 1.8B | 1.2B | 992.9M |
| Basic EPS | — | 1.5 | 1.0 | 0.8 |
| Diluted EPS | — | 1.5 | 1.0 | 0.8 |
| Basic average shares | — | 1.2B | 1.2B | 1.2B |
| Diluted average shares | — | 1.2B | 1.2B | 1.2B |
| EBITDA | 3.7B | 3.9B | 3.0B | 2.8B |
| Net income from continuing op. | 2.1B | 2.3B | 1.4B | 1.3B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |